Literature DB >> 19072225

Characterization of poly(ethylene glycol) and PEGylated products by LC/MS with postcolumn addition of amines.

Lihua Huang1, P Clayton Gough, Michael R Defelippis.   

Abstract

PEGylation of peptides and proteins presents significant challenges for structural characterization due to the heterogeneity of the poly(ethylene glycol) (PEG), the number of PEG moieties attached, and the site(s) of PEGylation. In this work, a novel and powerful methodology using a postcolumn addition combined with LC/MS was developed and applied to examine high molecular weight (>/=20 kDa) PEG as well as PEGylated peptide and protein products. The PEG and PEGylated compounds were eluted from RP-HPLC, and the HPLC stream was mixed with diethylmethylamine (DEMA) or triethylamine (TEA) through a T mixer coupled to a time-of-flight mass spectrometer. With these conditions, PEG is diethylmethyl- or triethyl-ammoniated instead of protonated while the protein or peptide remains protonated. The charges for PEG and the PEGylated compounds were greatly reduced, and there was no convolution among differently charged ions, even for 40 kDa PEG or tri-20 kDa PEGylated IgG4 heavy chain. Mass accuracies (<0.01%) obtained are similar to large molecular weight proteins. By selecting specific amines, such as DEMA, commercially available software was used to deconvolute the spectra composed of the diethylmethylammoniated PEG or the diethylmethylammoniated and protonated PEGylated peptide or protein to obtain accurate masses. The examples presented in this report demonstrate that the methodology can be used to elucidate different PEG structures and modifications, such as oxidation and maleimide ring opening of PEGylated peptides or proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19072225     DOI: 10.1021/ac801711u

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  7 in total

1.  Direct quantitative analysis of a 20 kDa PEGylated human calcitonin gene peptide antagonist in cynomolgus monkey serum using in-source CID and UPLC-MS/MS.

Authors:  Hongyan Li; Mark J Rose; Jerry Ryan Holder; Marie Wright; Les P Miranda; Christopher A James
Journal:  J Am Soc Mass Spectrom       Date:  2011-06-23       Impact factor: 3.109

2.  Electrospray ionization mechanisms for large polyethylene glycol chains studied through tandem ion mobility spectrometry.

Authors:  Carlos Larriba; Juan Fernandez de la Mora; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2014-06-13       Impact factor: 3.109

3.  Elucidation of PEGylation site with a combined approach of in-source fragmentation and CID MS/MS.

Authors:  Xiaojun Lu; P Clayton Gough; Michael R DeFelippis; Lihua Huang
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-25       Impact factor: 3.109

4.  Using hydrogen/deuterium exchange mass spectrometry to study conformational changes in granulocyte colony stimulating factor upon PEGylation.

Authors:  Hui Wei; Joomi Ahn; Ying Qing Yu; Adrienne Tymiak; John R Engen; Guodong Chen
Journal:  J Am Soc Mass Spectrom       Date:  2012-01-07       Impact factor: 3.109

5.  Electrospray ionization tandem mass spectrometry of ammonium cationized polyethers.

Authors:  Andreas Nasioudis; Ron M A Heeren; Irene van Doormalen; Nicolette de Wijs-Rot; Oscar F van den Brink
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-05       Impact factor: 3.109

6.  A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner.

Authors:  Volker Schellenberger; Chia-Wei Wang; Nathan C Geething; Benjamin J Spink; Andrew Campbell; Wayne To; Michael D Scholle; Yong Yin; Yi Yao; Oren Bogin; Jeffrey L Cleland; Joshua Silverman; Willem P C Stemmer
Journal:  Nat Biotechnol       Date:  2009-12       Impact factor: 54.908

7.  Aqueous Solutions of Peptides and Trialkylamines Lead to Unexpected Peptide Modification.

Authors:  Yiran Ma; Puja J Gandhi; James P Reilly
Journal:  Molecules       Date:  2021-10-27       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.